Epcoritamab for treating relapsed or refractory follicular lymphoma after 2 or more lines of systemic treatment TA1139 11 March 2026 11 March 2026 Durvalumab with gemcitabine and cisplatin for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results